Case Study: Trace Biosciences accelerates its first IND submission with Weave

Trace Biosciences reduces IND drafting and revision time with Weave

Trace Biosciences, an emerging biotech company, faced the challenge of preparing its first Investigational New Drug (IND) application under tight timelines. As a first-time sponsor, the team needed a solution to coordinate scientific input and maintain consistency across document modules without sacrificing human-led scientific and regulatory judgment. They turned to vendor Weave to help manage this complex drafting process.

Weave provided a solution that utilized structured drafting templates and AI-assisted workflows to accelerate content generation and improve cross-section alignment. This approach allowed Trace Biosciences to maintain expert oversight while significantly reducing drafting and revision time. The result was the successful submission of their first IND, which built a clear and consistent regulatory argument while keeping pace with evolving data.

Trace Biosciences